CHROMADEX CORP.

Profile

Company Names

CHROMADEX CORP.

Addresses

10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA 90024

10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES, CA 90024

10900 WILSHIRE BOULEVARD, SUITE 650, LOS ANGELES, CA 90024

10005 MUIRLANDS BLVD., SUITE G, IRVINE, CA 92618

10005 MUIRLANDS BLVD., STE. G, FIRST FLOOR, IRVINE, CA 92618

10005 MUIRLANDS BLVD., SUITE G, FIRST FLOOR, IRVINE, CA 92618

10005 MUIRLANDS BOULEVARD, SUITE G, FIRST FLOOR, IRVINE, CA 92618

Phone Numbers

310-388-6706
949-419-0288
949 419 0288

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$110,419,990.00

Number of Funding Rounds:

15
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
15
2022-09-30 
$3,100,000.00 
$3,100,000.00 
$0.00 
Equity 
14
2021-02-23 
$24,999,995.00 
$24,999,995.00 
$0.00 
Equity 
13
2020-05-07 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
12
2019-08-15 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
11
2019-05-17 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
10
2017-11-17 
$22,999,996.00 
$22,999,996.00 
$0.00 
Equity 
9
2017-08-18 
$5,110,084.00 
$5,110,084.00 
$0.00 
Equity 
8
2017-05-24 
$16,389,916.00 
$16,389,916.00 
$0.00 
Equity 
7
2017-04-27 
$3,500,000.00 
$3,500,000.00 
$0.00 
Equity 
6
2017-03-12 
$1,000,003.00 
$1,000,003.00 
$0.00 
Equity 
5
2016-03-11 
$500,000.00 
$500,000.00 
$0.00 
 
4
2014-09-29 
$445,000.00 
$445,000.00 
$0.00 
 
3
2013-10-17 
$3,000,000.00 
$3,500,000.00 
$500,000.00 
Equity 
2
2012-02-10 
$3,699,998.00 
$3,699,998.00 
$0.00 
Equity 
1
2010-05-20 
$3,674,998.00 
$9,187,494.00 
$5,512,496.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
 
ALLEN 
DIRECTOR
CHROMADEX CORP.
STEPHEN 
L. 
ALLEN 
DIRECTOR
CHROMADEX CORP.
STEVE 
 
ALLEN 
DIRECTOR
SENSOR INNOVATIONS INC   |  NUECES CAPITAL LTD   |  CHROMADEX CORP.   |  CARITAS ROYALTY FUND LLC   |  HEALTHPLAN DATA SOLUTIONS, INC.
STEVE 
L. 
ALLEN 
DIRECTOR
CHROMADEX CORP.
JEFF 
 
BAXTER 
DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.   |  VBI VACCINES INC.   |  VBI VACCINES INC/BC   |  CHROMADEX CORP.
JEFF 
10005 MUIRLANDS BLVD., SUITE G 
BAXTER 
DIRECTOR
CHROMADEX CORP.
JEFF 
L. 
BAXTER 
DIRECTOR
CHROMADEX CORP.
STEPHEN 
 
BLOCK 
DIRECTOR
GREEN-BLUE 1818, L.L.C.   |  MASHER MEDIA INC.   |  CHROMADEX CORP.   |  MYLAB BOX, INC.
STEPHEN 
A. 
BLOCK 
DIRECTOR
ALLYLIX INC.   |  CHROMADEX CORP.
STEPHEN 
L. 
BLOCK 
DIRECTOR
CHROMADEX CORP.
STEVEN 
 
BLOCK 
DIRECTOR
CHROMADEX CORP.
STEVEN 
A. 
BLOCK 
DIRECTOR
CHROMADEX CORP.
LISA 
 
BRATKOVICH 
EXECUTIVE OFFICER
CHROMADEX CORP.
MICHAEL 
 
BRAUSER 
DIRECTOR
CHROMADEX CORP.   |  THREE KINGS OF QUEENS, INC.   |  UPSTREAM WORLDWIDE, INC.   |  USELL.COM, INC.   |  BEST ONE, INC.   |  IDI, INC.   |  MAJESCO ENTERTAINMENT CO   |  COGINT, INC.
ANN 
N. 
COHEN 
DIRECTOR
CHROMADEX CORP.
REID 
 
DABNEY 
DIRECTOR
CHROMADEX CORP.
REID 
J D 
DABNEY 
DIRECTOR
CHROMADEX CORP.
HUGH 
 
DUNKERLEY 
DIRECTOR
CHROMADEX CORP.
HUGH 
D P 
DUNKERLEY 
DIRECTOR
CHROMADEX CORP.
HUGH 
 
DUNKERLY 
DIRECTOR
CHROMADEX CORP.
KEVIN 
 
FARR 
EXECUTIVE OFFICER
CHROMADEX CORP.
KEVIN 
L. 
FARR 
EXECUTIVE OFFICER
CHROMADEX CORP.
KEVIN 
M. 
FARR 
EXECUTIVE OFFICER
CHROMADEX CORP.
ROB 
 
FRIED 
DIRECTOR
CHROMADEX CORP.
ROBERT 
 
FRIED 
EXECUTIVE OFFICER, DIRECTOR
SEARCHMEDIA HOLDINGS LTD   |  SENIORQUOTE INSURANCE SERVICES, INC.   |  IDI, INC.   |  CHROMADEX CORP.   |  RAPIDGROW LED TECHNOLOGIES, INC.   |  DAKODA.AI LLC
ROBERT 
L. 
FRIED 
EXECUTIVE OFFICER, DIRECTOR
CHROMADEX CORP.
ROBERT 
N. 
FRIED 
EXECUTIVE OFFICER, DIRECTOR
COGINT, INC.   |  CHROMADEX CORP.
MARK 
 
FRIEDMAN 
EXECUTIVE OFFICER
PHILIP MORRIS INTERNATIONAL INC.   |  ICONIX BRAND GROUP, INC.   |  PINKBERRY HOLDING CORP   |  ACCRUENT HOLDINGS, INC.   |  AXOGEN, INC.   |  DLD EVENT ONSHORE FUND, LP   |  PARK AVENUE PLAZA LLC   |  CHROMADEX CORP.   |  MAVERICK TOPCO, LLC   |  PANACEUTICS NUTRITION, INC.   |  DLD CONVERTIBLE ARBITRAGE ONSHORE FUND, LP   |  INTELERAD HOLDINGS TOPCO ULC   |  INTELERAD HOLDINGS ULC   |  DLD MASTER ONSHORE FUND, LP   |  DLD MASTER OFFSHORE FUND, LTD.   |  FIRST STOP HOLDINGS, LLC   |  RTP ANGEL FUND, LLC   |  OHEADS PROPCO HOLDINGS LLC
MARK 
L. 
FRIEDMAN 
EXECUTIVE OFFICER
BANYAN RAIL SERVICES INC.   |  CHROMADEX CORP.
BRIANNA 
N. 
GERBER 
EXECUTIVE OFFICER
CHROMADEX CORP.
MARK 
S. 
GERMAIN 
DIRECTOR
OMNIMMUNE HOLDINGS, INC.   |  CHROMADEX CORP.
MARK 
 
GERMAINE 
DIRECTOR
CHROMADEX CORP.
KURT 
 
GUSTAFSON 
DIRECTOR
CHROMADEX CORP.   |  XENCOR INC   |  OMNIAB, INC.
KURT 
L. 
GUSTAFSON 
DIRECTOR
CHROMADEX CORP.
GLENN 
L. 
HALPRYN 
DIRECTOR
CASTLE BRANDS INC   |  QUIKBYTE SOFTWARE INC   |  CHROMADEX CORP.   |  SORRENTO THERAPEUTICS, INC.
JEFFREY 
 
HIMMEL 
EXECUTIVE OFFICER, DIRECTOR
CHROMADEX CORP.
BARRY 
 
HONIG 
DIRECTOR
EMPIRE SPORTS + ENTERTAINMENT, CO.   |  EMPIRE SPORTS + ENTERTAINMENT HOLDINGS CO.   |  THREE KINGS OF QUEENS, INC.   |  SAGEBRUSH GOLD LTD.   |  PERSHING GOLD CORP.   |  CHROMADEX CORP.   |  BEST ONE, INC.   |  TRUCKPAY, INC.   |  MAJESCO ENTERTAINMENT CO   |  FC ACQUISITION, INC.
BARRY 
C. 
HONIG 
DIRECTOR
CHROMADEX CORP.   |  PERSHING GOLD CORP.
FRANK 
 
JAKSCH 
EXECUTIVE OFFICER, DIRECTOR
CHROMADEX CORP.   |  LIQUID SCIENCE HOLDINGS, LLC
FRANK 
L. 
JAKSCH 
EXECUTIVE OFFICER, DIRECTOR
CHROMADEX CORP.
FRANK 
L. JR. 
JAKSCH 
DIRECTOR
CHROMADEX CORP.
FRANK, JR. 
 
JAKSCH 
EXECUTIVE OFFICER, DIRECTOR
CHROMADEX CORP.
FRANK 
L. 
JAKSCH, JR. 
EXECUTIVE OFFICER, DIRECTOR
CHROMADEX CORP.
MEGAN 
 
JORDAN 
EXECUTIVE OFFICER
CHROMADEX CORP.
TONY 
 
LAU 
DIRECTOR
SIMPLEX INVESTMENT FUND I, LLC   |  CHROMADEX CORP.
TONY 
L. 
LAU 
DIRECTOR
CHROMADEX CORP.
TSZ HO TONY 
L. 
LAU 
DIRECTOR
CHROMADEX CORP.
CURTIS 
 
LOCKSHIN 
DIRECTOR
QUIKBYTE SOFTWARE INC   |  CHROMADEX CORP.   |  RXI PHARMACEUTICALS CORP   |  XENETIC BIOSCIENCES, INC.
CURTIS 
A. 
LOCKSHIN 
DIRECTOR
CHROMADEX CORP.   |  PHIO PHARMACEUTICALS CORP.
GARY 
N. 
NG 
DIRECTOR
CHROMADEX CORP.
KRISTIN 
N. 
PATRICK 
DIRECTOR
CHROMADEX CORP.
TROY 
 
RHONEMUS 
EXECUTIVE OFFICER
CHROMADEX CORP.
TROY 
L. 
RHONEMUS 
EXECUTIVE OFFICER
CHROMADEX CORP.
MATTHEW 
 
ROBERTS 
EXECUTIVE OFFICER
MELTZ, INC.   |  MELTZ, LLC   |  SNAG HOLDINGS, INC.   |  CHROMADEX CORP.   |  QUAIL INVESTMENT HOLDINGS LLC   |  SUTTON BANCSHARES, INC.   |  EAGLE INVESTMENT HOLDINGS-K II LLC   |  PRYSM CAPITAL FUND I, L.P.   |  NUTR, INC.   |  TRIANGLE INVESTMENT OPPORTUNITIES, L.P.   |  PRYSM CAPITAL FUND II, L.P.   |  PRYSM CAPITAL FUND II-C, L.P.   |  PRYSM PINE INVESTMENT OPPORTUNITIES II, L.P.   |  ALEMBIC TECHNOLOGIES, INC.   |  CLEAR STREET GROUP INC.   |  CHOWBUS, INC.   |  PRYSM LOBOS INVESTMENT OPPORTUNITIES, L.P.
STEVEN 
 
RUBIN 
DIRECTOR
NEOVASC INC   |  CARDO MEDICAL, INC.   |  BIOZONE PHARMACEUTICALS, INC.   |  SEVION THERAPEUTICS, INC.   |  ONSOURCE, LLC   |  IDI, INC.   |  VBI VACCINES INC/BC   |  CHROMADEX CORP.   |  HUMBITION II, LLC
STEVEN 
L. 
RUBIN 
DIRECTOR
CHROMADEX CORP.
STEVEN 
N. 
RUBIN 
DIRECTOR
CHROMADEX CORP.
HAMED 
N. 
SHAHBAZI 
DIRECTOR
CHROMADEX CORP.
TROY 
 
THONEMUS 
EXECUTIVE OFFICER
CHROMADEX CORP.
THOMAS 
 
VARVARO 
EXECUTIVE OFFICER
CHROMADEX CORP.   |  MABVAX THERAPEUTICS HOLDINGS, INC.   |  LIQUID SCIENCE HOLDINGS, LLC
THOMAS 
C. 
VARVARO 
EXECUTIVE OFFICER
CHROMADEX CORP.   |  MABVAX THERAPEUTICS HOLDINGS, INC.
THOMAS 
L. 
VARVARO 
EXECUTIVE OFFICER
CHROMADEX CORP.
TOM 
 
VARVARO 
EXECUTIVE OFFICER
CHROMADEX CORP.
WENDY 
 
YU 
DIRECTOR
CHROMADEX CORP.
WENDY 
L. 
YU 
DIRECTOR
CHROMADEX CORP.
WENDY 
N. 
YU 
DIRECTOR
CHROMADEX CORP.
WING TAK WENDY 
L. 
YU 
DIRECTOR
CHROMADEX CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-14
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
2021-03-03
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2021-02-23 
2020-05-20
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2020-05-07 
2019-08-29
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2019-08-15 
2019-05-24
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2019-05-17 
2017-11-29
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2017-11-17 
2017-08-31
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2017-08-18 
2017-06-06
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2017-05-24 
2017-05-05
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2017-04-27 
2017-03-22
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2017-03-12 
2016-03-16
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
 
2016-03-11 
2014-10-14
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
 
2014-09-29 
2013-10-24
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2013-10-17 
2012-02-22
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$5,000,001 - $25,000,000 
Equity 
2012-02-10 
2010-05-27
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$1,000,001 - $5,000,000 
Equity 
2010-05-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
OPPENHEIMER + CO. INC.
105559
LADENBURG THALMANN AND CO. INC.
505
LADENBURG THALMANN AND CO. INC.
505
NONE
NONE
PALLADIUM CAPITAL ADVISORS, LLC
129400
NONE
NONE
AEGIS CAPITAL CORP.
15007